Oxidation of serotonin by superoxide radical: Implications to neurodegenerative brain disorders

Chemical Research in Toxicology

Volumn 11, Issue 6, 1998, Pages 639-650

  Wrona, Monika Z ^a   Dryhurst, Glenn ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; METHAMPHETAMINE; SEROTONIN; SUPEROXIDE;

ALZHEIMER DISEASE; ARTICLE; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; NEUROTOXICITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; REACTION ANALYSIS; REPERFUSION INJURY; SEROTONIN METABOLISM;

ANTIOXIDANTS; BRAIN DISEASES; FREE RADICAL SCAVENGERS; FREE RADICALS; GLUTATHIONE; HUMANS; INDOLEQUINONES; IRON CHELATING AGENTS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; PROTEIN BINDING; SEROTONIN; SUPEROXIDES; TRYPTAMINES;

EID: 0031802887     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx970185w     Document Type: Article

References (70)

1. Markesbery, W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biol. Med. 23, 134-137.
2. Jenner, P., Dexter, D. T., Sian, J., Schapira, A. H. V., and Marsden C. D. (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann. Neurol. 32, S83-S87.
3. Oliver, C. N., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M., and Floyd, R. A. (1990) Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia-reperfusion-induced injury in gerbil brain. Proc. Natl Acad. Sci. U.S.A. 87, 5144-5147.
4. Hirata, H., Ladenheim, B., Rothman, R. B., Epstein, C., and Cadet, J. L. (1995) Methamphetamine-induced serotonin neurotoxicity is mediated by Superoxide radicals. Brain Res. 677, 345-347.
5. Simonian, N. A., and Coyle, J. T. (1996) Oxidative stress in neurodegenerative diseases. Anna. Rev. Pharmacol. Toxicol. 36, 83-106.
6. Halliwell, B. (1992) Oxygen radicals as key mediators in neurological disease: Fact or fiction? Ann. Neurol. 32, S10-S15.
7. Globus, M. Y.-T., Wester, P., Busto, R., and Dietrich, W. D. (1992) Ischemia-induced extracellular release of serotonin plays a role in CA1 neuronal cell death in rats. Stroke 23, 1595-1601.
8. Globus, M. Y.-T., Busto, R., Dietrich, W. D., Martinez, E., Valdés, I., and Ginsberg, M. D. (1989) Direct evidence for acute and massive norepinephrine release in hippocampus during transient ischemia. J. Cereb. Blood Flow Metab. 9, 842-846.
9. Phebus, L. A., and Clemens, J. A. (1989) Effects of transient global cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites. Life Sci. 44, 1335-1342.
10. [10) Benveniste, H., Drejer, J., Schouboe, A., and Diemer, N. H. (1984) Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
11. Weinberger, J., Cohen, G., and Nieves-Rosa, J. (1983) Nerve terminal damage in cerebral ischemia: Greater susceptibility of catecholamine nerve terminals relative to serotonin nerve terminals. Stroke 14, 986-989.
12. Sakamoto, A., Ohnishi, S. T., Ohnishi, T., and Ogawa, R. (1991) Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in rat brain. Brain Res. 554, 186-192.
13. Yang, G. Y., Chan, P. H., Chen, J., Carlson, E., Chen, S. F., Weinstein, P., Epstein, C. J., and Kamii, H. (1994) Human copper-zinc Superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25, 165-170.
14. Onodera, H., Iijima, K., and Kogure, K. (1986) Mononucleotide metabolism in the rat brain after transient ischemia. J. Neurochem. 46, 1704-1710.
15. Kinuta, Y., Kimura, M., Itokawa, Y., Ishikawa, M., and Kikuchi, H. (1989) Changes in xanthine oxidase in ischemic rat brain. J. Neurosurg. 71, 417-420.
16. Choi, D. W. (1988) Glutamate neurotoxicity and diseases of the nervous sytem. Neuron 1, 623-634.
17. Lafon-Cazal, M., Pletri, S., Calcusi, M., and Bockaert J. (1993) NMDA-dependent Superoxide production and neurotoxicity. Nature 364, 535-537.
18. Bowyer, J. F., and Holson, R. R. (1995) Methamphetamine and amphetamine neurotoxicity. In Handbook of Neurotoxicology (Chang, L. W., and Dyer, R. S., Eds.) pp 845-870, Marcel Dekker, New York.
19. Gibb, J. W., Hanson, G. R., and Johnson, M. (1994) Neurochemical mechanisms of toxicity. In Amphetamine and Its Analogues: Psychopharmacology, Toxicology and Abuse (Cho, A. K., and Segal, D. S., Eds.) pp 269-295, Academic Press, New York.
20. Seiden, L. S., and Sabol, K. E. (1995) Neurotoxicity of methamphetamine-related drugs and cocaine. In Handbook of Neurotoxicology (Chang, L. W., and Dyer, R. S., Eds.) pp 825-843, Marcel Dekker, New York.
21. Commins, D. L., and Seiden, L.-S. (1986) α-Methyltyrosine blocks methamphetamine-induced degeneration in the rat somatosensory cortex. Brain Res. 365, 15-20.
22. De Vito, M. J., and Wagner, G. C. (1989) Methamphetamine-induced neuronal damage: A possible role for free radicals. Neuropharmacology 28, 1145-1150.
23. Schmidt, C. J., and Gibb, J. W. (1985) Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: Effects of amfonelic acid. Eur. J. Pharmacol. 109, 73-80.
24. Ricaurte, G. A., Fuller, R. W., Perry, K. W., Seiden, L. S., and Schuster, C. R. (1983) Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine. Neuropharmacology 22, 1165-1169.
25. Busto, R., Harik, S. L, Yoshida, S., Scheinberg, P., and Ginsberg, M. D. (1985) Cerebral norepinephrine depletion enhances recovery after brain ischemia. Ann. Neurol. 18, 329-336.
26. Weinberger, J., Nieves-Rosa, J., and Cohen, G. (1985) Nerve terminal damage in cerebral ischemia: protective effects of alpha-methyl-para-tyrosine. Stroke 16, 864-870.
27. Globus, M. Y.-T., Ginsberg, M. D., Dietrich, W. D., Busto, R., and Scheinberg, P. (1987) Substantia nigra lesion protects against ischemic damage to the striatum. Neurosci. Lett. 80, 251-256.
28. Axt, K., Commins, D. L., Vosmer, G., and Seiden, L. S. (1990) α-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced neurotoxin formation. Brain Res. 515, 269-276.
29. Maher, P., and Davis, J. B. (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16, 6394-6401.
30. Commins, D. L., Axt, K. J., and Seiden, L.-S. (1987) 5,6-Dihydroxytryptamine, a serotonergic neurotoxin, is formed endogenously in the rat brain. Brain Hes. 403, 7-14.
31. Seiden, L. S., and Vosmer, G. (1984) Formation of 6-hydroxy-dopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol. Biochem. Behav. 21, 29-31.
32. Rollema, H., De Vries, J. B., Westerink, B. H. C., Van Putten, F. M., and Horn, A. S. (1986) Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP. Eur. J. Pharmacol. 132, 65-69.
33. Karoum, F., Chrapusta, S. J., Egan, M. F., and Wyatt, R. J. (1993) Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study. J. Neurochem. 61, 1369-1375.
34. Yang, Z., Wrona, M. Z., and Dryhurst, G. (1997) 5-Hydroxy-3-(ethylamino) -2-oxindole is not formed in rat brain following a neurotoxic dose of methamphetamine: Evidence that methamphetamine does not induce hydroxyl radical-mediated oxidation of serotonin. J. Neurochem. 68, 1929-1941.
35. Wrona, M. Z., Yang, Z., McAdams, M., O'Connor-Coates, S., and Dryhurst, G. (1995) Hydroxyl radical-mediated oxidation of serotonin: Potential insights into the neurotoxicity of methamphetamine. J. Neurochem. 64, 1390-1400.
36. Slivka, A., and Cohen, G. (1985) Hydroxyl radical attack on dopamine. J. Biol. Chem. 260, 15466-15472.
37. Singh, S., Wrona, M. Z., and Dryhurst, G. (1992) Synthesis and reactivity of the putative neurotoxin tryptamine-4,5-dione. Bioorg. Chem. 20, 189-203.
38. Wong, K.-S., Goyal, R. N., Wrona, M. Z., Blank, C. L., and Dryhurst, G. (1993) 7-S-Glutathionyl-tryptamine-4,5-dione: A possible aberrant metabolite of serotonin. Biochem. Pharmacol. 46, 1637-1652.
39. Wrona, M. Z., Singh, S., and Dryhurst, G. (1995) Influence of glutathione on the electrochemical and enzymatic oxidation of serotonin. J. Electroanal. Chem. 382, 41-51.
40. Wrona, M. Z., and Dryhurst, G. (1990) Electrochemical oxidation of 5-hydroxytryptamine in aqueous solution at physiological pH. Bioorg. Chem. 18, 291-317.
41. Halliwell, B., and Gutteridge, J. M. C. (1985) Free Radical in Biology and Medicine, Clarendon Press, Oxford.
42. Kappusamy, P., and Zweier, J. L. (1989) Characterization of free radical generation by xanthine oxidase. J. Biol. Chem. 264, 9880-9884.
43. Minotti, G., and Aust, S. D. (1989) The role of iron in oxygen radical mediated lipid peroxidation. Chem.-Biol. Interact. 71, 1-19.
44. Minotti, G., and Aust, S. D. (1992) Redox cycling of iron and lipid peroxidation. Lipids 27, 219-226.
45. Davies, M. J., Donkor, R., Dunster, C. A., Gee, C. A., Jonas, S., and Willson, R. L. (1987) Desferrioxamine (desferal) and superoxide free radicals: Formation of an enzyme-dam aging nitroxide. Biochem. J. 246, 725-729.
46. Li, T., and Vallee, B. L. (1965) Reactivity and function of sulfhydryl groups in horse liver alcohol dehydrogenase. Biochemistry 4, 1195-1202.
47. Nanni, E. J., Stallings, M. D., and Sawyer, D. T. (1980) Does Superoxide ion oxidize catechol, α-tocopherol, and ascorbic acid by direct electron transfer? J. Am. Chem. Soc. 102, 4481-4485.
48. Sawyer, D, T., and Valentine, J. S. (1981) How super is superoxide? Ace. Chem. Res. 14, 393-400.
49. Sinhababu, A. K., and Borchardt, R. T. (1985) Mechanism and products of autoxidation of 5,7-dihydroxytryptamine. J. Am. Chem. Soc. 107, 7618-7627.
50. Tabatabaie, T., Wrona, M. Z., and Dryhurst, G. (1990) Autoxidation of the serotonergic neurotoxin 5,7-dihydroxytryptamine. J. Med, Chem. 33, 667-672.
51. Afanas'ev, I. B. (1989) Superoxide Ion: Chemistry and Biological Implications, Vol. I, pp 202-209, CRC Press, Boca Raton, FL, pp 202-209.
52. Slivka, A., Mytilineou, C. A., and Cohen, G. (1987) Histochemical evaluation of glutathione in brain. Brain Res. 409, 275-284.
53. Halliwell, B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
54. Volicer, L., Chen, J.-C., Crino, P. B., Vogt, B. A., Fishman, J., Rubins, J., Schnepper, P. W., and Wolfe, N. (1989) Neurotoxic properties of a serotonin oxidation product: Possible role in Alzheimer's disease. In Alzheimer's Disease and Related Disorders (Iqbal, K., Wisniewski, H. M., and Winblad, B., Eds.) pp 453-465, A. R. Liss, Inc., New York.
55. Crino, P. B., Vogt, B. A, Chen, J.-C., and Volicer, L. (1989) Neurotoxic effects of partially oxidized serotonin: Tryptamine-4,5-dione. Brain Res. 504, 247-257.
56. Chen, J.-C., Schnepper, P. W., To, A., and Volicer, L. (1992) Neurochemical changes in the rat brain after intraventricular administration of tryptamine-4,5-dione. Neuropharmacology 31, 215-219.
57. Li, H., and Dryhurst, G. (1997) Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxlic acid (DHBT-1) : A putative nigral endotoxin of relevance to Parkinson's disease. J. Neurochem. 69, 1530-1541.
58. Joseph, R., Welch, K. M. A., D'Andrea, G., and Riddle, J. M. (1989) Evidence for the presence of red and white cells within "platelet" aggregates formed in whole blood. Thromb. Res. 53, 485-491.
59. Hohnsen, H. (1987) Platelet secretion. In Thrombosis and Hemostasis. 2nd ed. (Colman, R. W., Hirsch, J., Marder, V. J., and Salzman, E. W., Eds.) pp 606-617, J. B. Lippincott Co., PA.
60. Hervonen, H., Steinwall, O., Spatz, M., and Klatzo, I. (1980) Behavior of the blood-brain barrier towards biogenic amines in experimental cerebral ischemia. Adv. Exp. Med. Biol. 131, 295-305.
61. Joseph, R., Tsering, C., Grunfeld, S., and Welch, K. M. A. (1992) Platelet secretory products may contribute to neuronal injury Stroke 22, 1448-1451.
62. Besnard, F., Perraud, F., Sensenbrenner, M., and Labourdette, G. (1987) Platelet-derived growth factor is a mitogen for glial but not for neuronal rat brain cells in vitro. Neurosci. Lett. 73, 287-292.
63. Banati, R. B., Schubert, P., Rothe, G., Gehrmann, J., Rudolphi, K., Valet, G., and Kreutzberg, G. W. (1994) Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by protentofylline. J. Cereb. Blood Flow Metab. 14, 145-149.
64. Colton, C., and Gilbert, D. (1987) Production of Superoxide anions by a CNS macrophage, the microglia. FEES Lett. 223, 284-288.
65. Schuff-Werner, P., Splettstösser, W., Schmidt, F, and Huether, G. (1995) Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of human mononuclear and polymorphonuclear phagocytes. Eur. J. Clin. Invest. 25, 477-484.
66. Huether, G., Fettk̈tter, I., Keilhoff, G., and Wolf, G. (1997) Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of activated microglia. J. Neurochem. 69, 2096-2101.
67. Fishman, J. B., Jordon, J. B., Chen, J.-C., Dickey, B. F., and Volker, L. (1991) Modification of brain guanine nucleotide-binding regulatory proteins by tryptamine-4,5-dione, a neurotoxic derivative of serotonin. J. Neurochem. 56, 1851-1854.
68. Matsushima, H., Shimohama, S., Fujimoto, S., Takenawa, T., and Kimura, J. (1995) Changes in platelet phopholipase C protein level in Alzheimer's disease. Neurobiol. Aging 16, 895-899.
69. Mastrogiacomo, F., Bergeron, C., and Kish, S. J. (1993) Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J. Neurochem. 61, 2007-2014.
70. Grammas, P., Moore, P., Botchlet, T., Hanson-Painton, O., Cooper, D. R., Ball, M. J., and Roher, A. (1995) Cerebral microvessels in Alzheimer's have reduced protein kinase C activity. Neurobiol. Aging 16, 563-569.